JA

Jebin Aktar Bhuyan

Active Director Designated Partner DIN 10777881
DIN 10777881 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jebin Aktar Bhuyan

Data last updated:

Jebin Aktar Bhuyan is a Designated Partner at Rilian Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10777881
Primary Designation Designated Partner
Industry Pharma
First Appointment 16 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Sep 20242024Active

Board colleagues of Jebin Aktar Bhuyan

NameDINCompanyDesignation
Mausin Akram10777880Rilian Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rilian Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Jebin Aktar Bhuyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jebin Aktar Bhuyan

Jebin Aktar Bhuyan currently holds 1 directorship: Rilian Pharmaceuticals Llp (Designated Partner, since 16 Sep 2024).

Jebin Aktar Bhuyan was first appointed on 16 Sep 2024 as Designated Partner at Rilian Pharmaceuticals Llp.

The current boards of Jebin Aktar Bhuyan's companies include Mausin Akram (Rilian Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available